4//SEC Filing
Broadfin Healthcare Master Fund Ltd 4
Accession 0001103021-21-000110
CIK 0001103021other
Filed
Nov 8, 7:00 PM ET
Accepted
Nov 9, 10:28 AM ET
Size
8.9 KB
Accession
0001103021-21-000110
Insider Transaction Report
Form 4
Broadfin Capital, LLC
Director
Transactions
- Purchase
Common Stock
2021-11-05$3.47/sh+257,800$894,566→ 4,958,489 total(indirect: See Footnote)
Transactions
- Purchase
Common Stock
2021-11-05$3.47/sh+257,800$894,566→ 4,958,489 total(indirect: See Footnote)
KOTLER KEVIN
Director
Transactions
- Purchase
Common Stock
2021-11-05$3.47/sh+257,800$894,566→ 4,958,489 total(indirect: See Footnote)
Footnotes (2)
- [F1]There are 4,400,689 shares of Common Stock held in the account of Broadfin Healthcare Master Fund, Ltd., a private investment fund managed by Broadfin Capital, LLC, and may be deemed to be beneficially owned by Kevin Kotler, managing member of Broadfin Capital, LLC. Kevin Kotler affirmatively (i) disclaims beneficial ownership of the reportable securities, (ii) states that this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 ("Section 16") of the Securities Exchange Act of 1934, as amended (the "Act") or any other purpose, except to the extent of his pecuniary interest therein, and (iii) disclaims being a "group" for purposes of Section 16.
- [F2]557,800 shares of Common Stock are held in the account of Broadfin Holdings, LLC., a private investment fund, and are deemed to be beneficially owned by Kevin Kotler, managing member of Broadfin Holdings, LLC.
Documents
Issuer
BIODELIVERY SCIENCES INTERNATIONAL INC
CIK 0001103021
Entity typeother
Related Parties
1- filerCIK 0001511900
Filing Metadata
- Form type
- 4
- Filed
- Nov 8, 7:00 PM ET
- Accepted
- Nov 9, 10:28 AM ET
- Size
- 8.9 KB